Literature DB >> 9886929

Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+ exchanger isoform NHE3.

S Akhter1, S K Nath, C M Tse, J Williams, M Zasloff, M Donowitz.   

Abstract

Squalamine, an endogenous molecule found in the liver and other tissues of Squalus acanthias, has antibiotic properties and causes changes in endothelial cell shape. The latter suggested that its potential targets might include transport proteins that control cell volume or cell shape. The effect of purified squalamine was examined on cloned Na+/H+ exchanger isoforms NHE1, NHE2, and NHE3 stably transfected in PS120 fibroblasts. Squalamine (1-h pretreatment) decreased the maximal velocity of rabbit NHE3 in a concentration-dependent manner (13, 47, and 57% inhibition with 3, 5, and 7 micrograms/ml, respectively) and also increased K'[H+]i. Squalamine did not affect rabbit NHE1 or NHE2 function. The inhibitory effect of squalamine was 1) time dependent, with no effect of immediate addition and maximum effect with 1 h of exposure, and 2) fully reversible. Squalamine pretreatment of the ileum for 60 min inhibited brush-border membrane vesicle Na+/H+ activity by 51%. Further investigation into the mechanism of squalamine's effects showed that squalamine required the COOH-terminal 76 amino acids of NHE3. Squalamine had no cytotoxic effect at the concentrations studied, as indicated by monitoring lactate dehydrogenase release. These results indicate that squalamine 1) is a specific inhibitor of the brush-border NHE isoform NHE3 and not NHE1 or NHE2, 2) acts in a nontoxic and fully reversible manner, and 3) has a delayed effect, indicating that it may influence brush-border Na+/H+ exchanger function indirectly, through an intracellular signaling pathway or by acting as an intracellular modulator.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886929     DOI: 10.1152/ajpcell.1999.276.1.C136

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Angiogenesis inhibitors.

Authors:  T R Tennant; C W Rinker-Schaeffer; W M Stadler
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

2.  Membrane surface charge dictates the structure and function of the epithelial Na+/H+ exchanger.

Authors:  Robert Todd Alexander; Valentin Jaumouillé; Tony Yeung; Wendy Furuya; Iskra Peltekova; Annie Boucher; Michael Zasloff; John Orlowski; Sergio Grinstein
Journal:  EMBO J       Date:  2011-01-18       Impact factor: 11.598

3.  Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.

Authors:  Diana C Márquez-Garbán; Manuel Gorrín-Rivas; Hsiao-Wang Chen; Colin Sterling; David Elashoff; Nalo Hamilton; Richard J Pietras
Journal:  Cancer Lett       Date:  2019-02-13       Impact factor: 8.679

Review 4.  Squalamine and Its Aminosterol Derivatives: Overview of Biological Effects and Mechanisms of Action of Compounds with Multiple Therapeutic Applications.

Authors:  Nour Mammari; Elsa Salles; Audrey Beaussart; Sofiane El-Kirat-Chatel; Mihayl Varbanov
Journal:  Microorganisms       Date:  2022-06-13

Review 5.  Targeted therapy for lung cancer.

Authors:  Rajesh Kukunoor; Jigar Shah; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

6.  A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension.

Authors:  Minghui Xiang; Mingye Feng; Sabina Muend; Rajini Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

7.  Antiangiogenic Steroids in Human Cancer Therapy.

Authors:  Richard J Pietras; Olga K Weinberg
Journal:  Evid Based Complement Alternat Med       Date:  2005-02-09       Impact factor: 2.629

8.  A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth.

Authors:  Sylvie Carmona; Jean-Michel Brunel; Rénaté Bonier; Véronique Sbarra; Stéphane Robert; Patrick Borentain; Dominique Lombardo; Eric Mas; René Gerolami
Journal:  Oncotarget       Date:  2019-11-19

Review 9.  Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research.

Authors:  Sukhmeen Kaur Kohli; Abhay Bhardwaj; Vinay Bhardwaj; Anket Sharma; Namarta Kalia; Marco Landi; Renu Bhardwaj
Journal:  Biomolecules       Date:  2020-04-09

10.  Evaluation of Cytotoxicity and α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids.

Authors:  Oxana B Kazakova; Gul'nara V Giniyatullina; Akhat G Mustafin; Denis A Babkov; Elena V Sokolova; Alexander A Spasov
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.